BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 29082243)

  • 1. Mammary and Extramammary Paget's Disease Presented Different Expression Pattern of Steroid Hormone Receptors.
    Zhou S; Zhong W; Mai R; Zhang G
    Biomed Res Int; 2017; 2017():3768247. PubMed ID: 29082243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of androgen signaling in androgen receptor-positive extramammary Paget's disease: Establishment of organoids and their biological analysis as a novel therapeutic target.
    Nakamura Y; Mizukami H; Tanese K; Fusumae T; Hirai I; Amagai M; Takamatsu R; Nakamura K; Nishihara H; Takimoto T; Ueno M; Saya H; Funakoshi T
    J Dermatol Sci; 2023 Oct; 112(1):23-30. PubMed ID: 37661472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical and clinicopathological study regarding nardilysin on extramammary Paget's disease.
    Yamaguchi A; Takahashi T; Kato T; Tanaka T; Nishi E; Fujimoto N
    Arch Dermatol Res; 2023 Sep; 315(7):1979-1987. PubMed ID: 36867223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole genome methylation sequencing reveals epigenetic landscape and abnormal expression of FABP5 in extramammary Paget's disease.
    Kang Z; Jiang L; Chen D; Yan G; Zhang G; Lai Y; Zeng Q; Wang X
    Skin Res Technol; 2023 Oct; 29(10):e13497. PubMed ID: 37881057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of extramammary Paget's disease in urban China: a population-based study.
    Yin S; Xu L; Wang S; Feng J; Liu L; Liu G; Wang J; Zhan S; Zhao Z; Gao P
    Orphanet J Rare Dis; 2021 Mar; 16(1):134. PubMed ID: 33731175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NECTIN4-targeted antibody-drug conjugate is a potential therapeutic option for extramammary Paget disease.
    Tanaka Y; Ito T; Murata M; Tanegashima K; Kaku-Ito Y; Nakahara T
    Exp Dermatol; 2024 Mar; 33(3):e15049. PubMed ID: 38509717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Definitive Radiotherapy for Penoscrotal Extramammary Paget's Disease: A Case Report with Long-Term Follow-Up.
    Suzuki G; Machida K; Asato A; Seri S; Ikemoto C; Yamazaki H; Yamada K; Katsumori T
    Clin Med Insights Case Rep; 2021; 14():11795476211009251. PubMed ID: 33953632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDK4: A Novel Therapeutic Target for Extramammary Paget's Disease.
    Hashimoto H; Kaku-Ito Y; Oda Y; Ito T
    Front Oncol; 2021; 11():710378. PubMed ID: 34395284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The utility of p63, CK7, and CAM5.2 staining in differentiating pagetoid intraepidermal carcinomas.
    Wieland R; Adhikari P; North J
    J Cutan Pathol; 2023 Dec; 50(12):1110-1115. PubMed ID: 37203381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulated expression of glucose transporter isoform 1 in invasive and metastatic extramammary Paget's disease.
    Matsumoto M; Rokunohe D; Sasaki T; Matsuzaki Y; Nakano H; Mizukami H; Akasaka E; Sawamura D
    Exp Ther Med; 2024 May; 27(5):228. PubMed ID: 38596658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a rare MET variant in a familial case of extramammary Paget's disease.
    Kobayashi Y; Nakamura Y; Tahara U; Nakamura K; Nakanishi K; Miyagawa A; Horikawa H; Kobayashi K; Funakoshi T; Sugano K; Ushiama M; Yoshida T; Inazumi T
    Clin Exp Dermatol; 2024 Mar; ():. PubMed ID: 38499767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of penoscrotal extramammary Paget disease: case series and review of the literature.
    Moretto P; Nair VJ; Hallani SE; Malone S; Belanger E; Morash C; Canil CM
    Curr Oncol; 2013 Aug; 20(4):e311-20. PubMed ID: 23904770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Pictorial Exploration of Mammary Paget Disease: Insights and Perspectives.
    Mariano L; Nicosia L; Pupo D; Olivieri AM; Scolari S; Pesapane F; Latronico A; Bozzini AC; Fusco N; Blanco MC; Mazzarol G; Corso G; Galimberti VE; Venturini M; Pizzamiglio M; Cassano E
    Cancers (Basel); 2023 Nov; 15(21):. PubMed ID: 37958452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of lipoma preferred partner in mammary and extramammary Paget disease.
    Liu Y; Wang Y; Qi R; Mao X; Jin F
    Medicine (Baltimore); 2020 Dec; 99(51):e23443. PubMed ID: 33371071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Msi1-mTOR pathway drives the pathogenesis of mammary and extramammary Paget's disease.
    Song Y; Guerrero-Juarez CF; Chen Z; Tang Y; Ma X; Lv C; Bi X; Deng M; Bu L; Tian Y; Liu R; Zhao R; Xu J; Sheng X; Du S; Liu Y; Zhu Y; Shan SJ; Chen HD; Zhao Y; Zhou G; Shuai J; Ren F; Xue L; Ying Z; Dai X; Lengner CJ; Andersen B; Plikus MV; Nie Q; Yu Z
    Cell Res; 2020 Oct; 30(10):854-872. PubMed ID: 32457396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent
    Takeichi T; Okuno Y; Matsumoto T; Tsunoda N; Suzuki K; Tanahashi K; Kono M; Kikumori T; Muro Y; Akiyama M
    Cancers (Basel); 2020 Mar; 12(4):. PubMed ID: 32235312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptome analyses reveal FOXA1 dysregulation in mammary and extramammary Paget's disease.
    Mai R; Zhou S; Zhou S; Zhong W; Hong L; Wang Y; Lu S; Pan J; Huang Y; Su M; Crawford R; Zhou Y; Zhang G
    Hum Pathol; 2018 Jul; 77():152-158. PubMed ID: 29630912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extramammary Paget Disease: a Therapeutic Challenge, for a Rare Entity.
    Pérez JC; Salgado AC; Pérez-Mies B; Rullán JAD; Ajuria-Illarramendi O; Alia EMG; Serrano Domingo JJ
    Curr Oncol Rep; 2023 Oct; 25(10):1081-1094. PubMed ID: 37421583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell origin and genome profile difference of penoscrotum invasive extramammary Paget disease compared with its
    Rao Y; Zhu J; Zheng H; Ren Y; Ji T
    Front Oncol; 2022; 12():972047. PubMed ID: 36091120
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.